Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents

Venetoclax (VEN) and hypomethylating agent (HMAs) regimens are emerging as the standard of care for unfit for chemotherapy acute myeloid leukemia (AML) patients, but the safety and feasibility of a total outpatient management have not been fully investigated. Fifty‐nine AML patients with active dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Papayannidis, Cristina, Nanni, Jacopo, Cristiano, Gianluca, Marconi, Giovanni, Sartor, Chiara, Parisi, Sarah, Zannoni, Letizia, Saed, Rashed, Ottaviani, Emanuela, Bandini, Lorenza, Testoni, Nicoletta, Baldazzi, Carmen, Solli, Vincenza, Ricci, Paolo, Di Giovanni Bezzi, Chiara, Abd‐alatif, Rania, Stanzani, Marta, Paolini, Stefania, Cavo, Michele, Curti, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314138/
https://www.ncbi.nlm.nih.gov/pubmed/35156731
http://dx.doi.org/10.1111/ejh.13753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314138/
https://www.ncbi.nlm.nih.gov/pubmed/35156731
http://dx.doi.org/10.1111/ejh.13753

Ejemplares similares